|Bid||126.30 x 800|
|Ask||126.45 x 800|
|Day's range||126.21 - 129.04|
|52-week range||126.21 - 165.35|
|Beta (5Y monthly)||N/A|
|PE ratio (TTM)||21.73|
|Earnings date||19 Oct 2022|
|Forward dividend & yield||N/A (N/A)|
|1y target est||155.51|
Procter & Gamble (PG) closed the most recent trading day at $126.25, moving -1.9% from the previous trading session.
If you're not familiar with Vertex Pharmaceuticals (NASDAQ: VRTX), this healthcare stock is certainly one to put on your radar. The company develops and manufactures medicines that treat rare diseases. As of right now, it has four approved products, and all of them treat cystic fibrosis.
Procter & Gamble (NYSE: PG) might be the ideal stock for today's environment. Its business has thrived through prior recessions with pricing power providing flexibility in the battle against inflation. As a holding, P&G can anchor a portfolio with its balance of sales growth and direct cash returns.